Home › Uveal Melanoma › California › Los Angeles
Uveal Melanoma clinical trials in Los Angeles, CA
6 studies for Uveal Melanoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
RecruitingPhase 3
- UCLA Medical Center, Los Angeles
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
RecruitingPhase 1/2
- UCLA Medical Center, Los Angeles
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecruitingPhase 3
- Jules Stein Eye Institute, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- The Angeles Clinic and Research Institute, Los Angeles
- University of California Los Angeles, Los Angeles
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingPhase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
RecruitingPhase 2
- The Angeles Clinic and Research Institute, Los Angeles
Uveal Melanoma trials in other cities
- Philadelphia, PA7 studies
- Nashville, TN6 studies
- Boston, MA5 studies
- Scottsdale, AZ5 studies
- New York City, NY5 studies
- Denver, CO5 studies
- Columbus, OH5 studies
- Houston, TX5 studies
- Pittsburgh, PA4 studies
- Aurora, CO4 studies
- Mountain View, CA4 studies
- Miami, FL4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.